Biomolecules is a prestigious, peer-reviewed journal published by MDPI that has been dedicated to advancing the field of biochemical research since its launch in 2011. With an impressive impact factor positioning it in Q1 for Biochemistry and Q2 for Molecular Biology as of 2023, this journal serves as a vital platform for disseminating high-quality research findings related to biological macromolecules, including proteins, nucleic acids, and carbohydrates. Operating as an Open Access journal, it ensures that vital research is accessible to all, furthering knowledge dissemination and collaboration within the scientific community. Located in Basel, Switzerland, the journal has established a significant presence in major academic databases, holding commendable Scopus rankings in both Biochemistry and Molecular Biology. Researchers, professionals, and students will find Biomolecules an invaluable resource for cutting-edge research, reviews, and insights in the rapidly evolving domains of biochemistry and molecular biology.

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

Current Plant Biology is a distinguished peer-reviewed journal published by ELSEVIER, focusing on the dynamic and rapidly evolving field of plant sciences. Since its inception as an Open Access publication in 2014, it has established itself as a leading platform for innovative research, boasting a remarkable Impact Factor that underscores its relevance and contribution to the scientific community. Based in the Netherlands, this journal caters to a diverse audience of researchers, professionals, and students, facilitating the dissemination of key findings in an array of disciplines including biochemistry, genetics, cell biology, and developmental biology. Recognized for its rigorous standards, Current Plant Biology holds a prestigious standing, classified within the Q1 and Q2 quartiles of various Scopus categories, reflecting its impact and reputation in the realms of Plant Science and related fields. The journal is committed to providing accessible and high-quality research outputs that inspire further investigation and collaboration in plant biology.

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

BIOCHEMISTRY is a premier academic journal published by the American Chemical Society, dedicated to advancing the field of biochemistry through the dissemination of high-quality research. With an ISSN of 0006-2960 and an e-ISSN of 1520-4995, this esteemed publication has been a vital resource since its inception in 1962 and continues to contribute to the scientific community, boasting a remarkable Q1 ranking in the field as of 2023. The journal's well-curated content emphasizes fundamental biochemical research, molecular genetics, and innovations in biochemical techniques, catering to a diverse audience of researchers, professionals, and students. Although not an open-access publication, BIOCHEMISTRY plays a crucial role in facilitating knowledge exchange and fostering academic collaboration globally, making significant contributions to the understanding of the biochemical processes that underpin life.

BIOCHEMISTRY-MOSCOW is a distinguished academic journal published by MAIK NAUKA/INTERPERIODICA/SPRINGER, focusing on pivotal research in the fields of biochemistry, biophysics, geriatrics, and broader medical sciences. Established in 1972, the journal has a rich history of disseminating critical findings and innovative studies, making significant contributions to the advancement of biochemical knowledge and applications. With its Q2 ranking in various categories including biochemistry and gerontology, the journal commands respect within the scientific community, offering a reputable platform for both established researchers and emerging scholars alike. Although traditionally not an open-access journal, it provides a wealth of information accessible through institutional subscriptions, ensuring the latest advancements reach a global audience. The journal aims to enhance understanding of biochemical processes and their implications for human health, and its commitment to high-quality peer-reviewed content has established it as a vital resource for those invested in the life sciences.

PROCESS BIOCHEMISTRY is a premier journal published by Elsevier Science Ltd, dedicated to advancing the field of biochemistry, microbiology, and bioengineering. With an ISSN of 1359-5113 and an E-ISSN of 1873-3298, this renowned journal is recognized for its impactful contributions, as demonstrated by its Q2 ranking in Applied Microbiology and Biotechnology, Biochemistry, and Bioengineering categories as of 2023. Covering a wide array of topics since its inception in 1950, PROCESS BIOCHEMISTRY serves as a crucial platform for researchers and professionals to disseminate innovative findings and develop new insights in enzyme technology, metabolic pathways, and bioreactor design. Although the journal operates under a non-open access policy, it remains vital for those engaged in cutting-edge biochemical research and development. Located in the United Kingdom, it continues to facilitate scientific discourse and foster collaboration among industry experts and academic scholars worldwide.